Published in Arthritis Rheum on September 15, 2008
2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. Pain Res Manag (2013) 1.70
Traditional Chinese Medicine for treatment of fibromyalgia: a systematic review of randomized controlled trials. J Altern Complement Med (2010) 1.41
Fibromyalgia: evolving concepts over the past 2 decades. CMAJ (2013) 1.18
A symptom-based approach to pharmacologic management of fibromyalgia. Nat Rev Rheumatol (2009) 1.13
Developments in the scientific and clinical understanding of fibromyalgia. Arthritis Res Ther (2009) 1.06
The FIBRO System: A Rapid Strategy for Assessment and Management of Fibromyalgia Syndrome. Ther Adv Musculoskelet Dis (2010) 0.90
[Pharmacological treatment of fibromyalgia syndrome]. Schmerz (2008) 0.87
Beyond pain in fibromyalgia: insights into the symptom of fatigue. Arthritis Res Ther (2013) 0.86
Neuropathic-like pain features and cross-sectional associations in rheumatoid arthritis. Arthritis Res Ther (2015) 0.85
Duloxetine: a review of its safety and efficacy in the management of fibromyalgia syndrome. J Cent Nerv Syst Dis (2010) 0.80
Escitalopram is associated with reductions in pain severity and pain interference in opioid dependent patients with depressive symptoms. Pain (2011) 0.78
Effect of Milnacipran on Pain in Patients with Rheumatoid Arthritis with Widespread Pain: A Randomized Blinded Crossover Trial. J Rheumatol (2015) 0.77
Pharmacotherapy for fibromyalgia. Front Pharmacol (2011) 0.76
Systematic review and network meta-analysis of interventions for fibromyalgia: a protocol. Syst Rev (2013) 0.76
Update on Treatment Guideline in Fibromyalgia Syndrome with Focus on Pharmacology. Biomedicines (2017) 0.75
Nortriptyline in knee osteoarthritis (NortIKA Study): study protocol for a randomised controlled trial. Trials (2015) 0.75
[Fibromyalgia]. Z Rheumatol (2011) 0.75
Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol (2011) 4.72
NeuPSIG guidelines on neuropathic pain assessment. Pain (2010) 4.04
Reduced dermal nerve fiber diameter in skin biopsies of patients with fibromyalgia. Pain (2015) 3.82
Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci (2003) 2.89
Non-specific, functional, and somatoform bodily complaints. Dtsch Arztebl Int (2012) 2.85
Small fibre pathology in patients with fibromyalgia syndrome. Brain (2013) 2.72
Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. Brain (2010) 2.35
Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res (Hoboken) (2013) 2.23
Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology (2012) 2.09
Treatment of fibromyalgia syndrome with gabapentin and pregabalin--a meta-analysis of randomized controlled trials. Pain (2009) 1.93
Chronically infused intrathecal morphine in dogs. Anesthesiology (2003) 1.93
The development of fibromyalgia--I: examination of rates and predictors in patients with rheumatoid arthritis (RA). Pain (2010) 1.92
Differential expression patterns of cytokines in complex regional pain syndrome. Pain (2007) 1.91
Human Stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats. Exp Neurol (2012) 1.81
TNF-α in CRPS and 'normal' trauma--significant differences between tissue and serum. Pain (2010) 1.74
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis (2012) 1.71
Efficacy of acupuncture in fibromyalgia syndrome--a systematic review with a meta-analysis of controlled clinical trials. Rheumatology (Oxford) (2010) 1.65
Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthritis Rheum (2006) 1.64
Functional and structural nerve fiber findings in heterozygote patients with Fabry disease. Pain (2009) 1.62
Fibromyalgia diagnosis and diagnostic criteria. Ann Med (2011) 1.58
Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis. JAMA (2009) 1.58
Local cytokine changes in complex regional pain syndrome type I (CRPS I) resolve after 6 months. Pain (2013) 1.52
Efficacy of cognitive-behavioral therapies in fibromyalgia syndrome - a systematic review and metaanalysis of randomized controlled trials. J Rheumatol (2010) 1.49
Selective serotonin reuptake inhibitors for fibromyalgia syndrome. Cochrane Database Syst Rev (2015) 1.46
What is fibromyalgia, how is it diagnosed, and what does it really mean? Arthritis Care Res (Hoboken) (2014) 1.45
Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition. Lancet Neurol (2010) 1.41
The longitudinal outcome of fibromyalgia: a study of 1555 patients. J Rheumatol (2011) 1.40
Opioids for chronic non-cancer pain: a critical view from the other side of the pond. Minerva Anestesiol (2015) 1.39
Intravenous immunoglobulin to fight complex regional pain syndromes: hopes and doubts. Ann Intern Med (2010) 1.38
Differential expression of cytokines in painful and painless neuropathies. Neurology (2007) 1.38
A key role for gp130 expressed on peripheral sensory nerves in pathological pain. J Neurosci (2009) 1.37
Selective increase of tumour necrosis factor-alpha in injured and spared myelinated primary afferents after chronic constrictive injury of rat sciatic nerve. Eur J Neurosci (2003) 1.32
Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis. Ann Rheum Dis (2012) 1.31
Activation of TRPV1 contributes to morphine tolerance: involvement of the mitogen-activated protein kinase signaling pathway. J Neurosci (2008) 1.31
T cell infiltration after chronic constriction injury of mouse sciatic nerve is associated with interleukin-17 expression. Exp Neurol (2006) 1.30
Systematic review with meta-analysis: cytokines in fibromyalgia syndrome. BMC Musculoskelet Disord (2011) 1.30
Mode of action of cytokines on nociceptive neurons. Exp Brain Res (2009) 1.26
Cognitive behavioural therapies for fibromyalgia. Cochrane Database Syst Rev (2013) 1.16
[The German Version of the Childhood Trauma Questionnaire (CTQ): psychometric characteristics in a representative sample of the general population]. Psychother Psychosom Med Psychol (2011) 1.16
Small fibers in Fabry disease: baseline and follow-up data under enzyme replacement therapy. J Peripher Nerv Syst (2011) 1.15
Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome. J Pain (2010) 1.15
Intramuscular injection of tumor necrosis factor-alpha induces muscle hyperalgesia in rats. Pain (2003) 1.15
Wallerian degeneration after crush injury of rat sciatic nerve increases endo- and epineurial tumor necrosis factor-alpha protein. Neurosci Lett (2004) 1.14
Emotional, physical, and sexual abuse in fibromyalgia syndrome: a systematic review with meta-analysis. Arthritis Care Res (Hoboken) (2011) 1.14
Early cytokine expression in mouse sciatic nerve after chronic constriction nerve injury depends on calpain. Brain Behav Immun (2007) 1.13
Pentoxifylline attenuates nociceptive sensitization and cytokine expression in a tibia fracture rat model of complex regional pain syndrome. Eur J Pain (2008) 1.13
Cutaneous neuropathy in Parkinson's disease: a window into brain pathology. Acta Neuropathol (2014) 1.12
Diagnostic validity of epidermal nerve fiber densities in painful sensory neuropathies. Muscle Nerve (2008) 1.12
TNF signaling contributes to the development of nociceptive sensitization in a tibia fracture model of complex regional pain syndrome type I. Pain (2007) 1.11
Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel. BMC Neurol (2011) 1.11
Efficacy and safety of meditative movement therapies in fibromyalgia syndrome: a systematic review and meta-analysis of randomized controlled trials. Rheumatol Int (2012) 1.10
Anterograde transport of tumor necrosis factor-alpha in the intact and injured rat sciatic nerve. J Neurosci (2002) 1.08
Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain (2013) 1.08
Physiological properties of spinal lamina II GABAergic neurons in mice following peripheral nerve injury. J Physiol (2006) 1.08
Patients with Fabry disease after enzyme replacement therapy dose reduction versus treatment switch. J Am Soc Nephrol (2014) 1.07
Cytokine regulation in animal models of neuropathic pain and in human diseases. Neurosci Lett (2008) 1.06
Absence of thermal hyperalgesia in serotonin transporter-deficient mice. J Neurosci (2003) 1.05
Differences in inflammatory pain in nNOS-, iNOS- and eNOS-deficient mice. Eur J Pain (2007) 1.05
Management of fibromyalgia syndrome--an interdisciplinary evidence-based guideline. Ger Med Sci (2008) 1.03
Sodium channel Na(v)1.7 is essential for lowering heat pain threshold after burn injury. J Neurosci (2012) 1.02
Musculoskeletal pain in patients with myotonic dystrophy type 2. Arch Neurol (2004) 1.02
Cyclooxygenase inhibition in nerve-injury- and TNF-induced hyperalgesia in the rat. Exp Neurol (2004) 1.01
Differential effect of endothelial nitric oxide synthase (NOS-III) on the regulation of adult neurogenesis and behaviour. Eur J Neurosci (2004) 1.00
Nitric oxide synthase modulates CFA-induced thermal hyperalgesia through cytokine regulation in mice. Mol Pain (2010) 1.00
Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study). J Peripher Nerv Syst (2013) 1.00
The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis. CNS Drugs (2012) 1.00
Untying chronic pain: prevalence and societal burden of chronic pain stages in the general population - a cross-sectional survey. BMC Public Health (2014) 0.99
Efficacy of hypnosis/guided imagery in fibromyalgia syndrome--a systematic review and meta-analysis of controlled trials. BMC Musculoskelet Disord (2011) 0.98
Tumor necrosis factor receptor 1 and 2 proteins are differentially regulated during Wallerian degeneration of mouse sciatic nerve. Exp Neurol (2005) 0.97
Review of pharmacological therapies in fibromyalgia syndrome. Arthritis Res Ther (2014) 0.96
Polysymptomatic distress in patients with rheumatoid arthritis: understanding disproportionate response and its spectrum. Arthritis Care Res (Hoboken) (2014) 0.95
Human stiff-person syndrome IgG induces anxious behavior in rats. PLoS One (2011) 0.95
Transient opening of the perineurial barrier for analgesic drug delivery. Proc Natl Acad Sci U S A (2012) 0.95
Efficacy of hydrotherapy in fibromyalgia syndrome--a meta-analysis of randomized controlled clinical trials. Rheumatology (Oxford) (2009) 0.95
Fighting off pain with resolvins. Nat Med (2010) 0.95
Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies. Acta Neuropathol (2003) 0.95
Antihyperalgesic efficacy of lacosamide in a rat model for muscle pain induced by TNF. Neuropharmacology (2007) 0.95
The role of mitogen-activated protein kinase (MAPK) in morphine tolerance and dependence. Mol Neurobiol (2009) 0.94
Anticytokine therapy in neuropathic pain management. Expert Rev Neurother (2007) 0.93
Hearing loss in fibromyalgia? Somatic sensory and non-sensory symptoms in patients with fibromyalgia and other rheumatic disorders. Clin Exp Rheumatol (2012) 0.93
Characterization of pain in fabry disease. Clin J Pain (2014) 0.92
Analysis of myelinated fibers in human skin biopsies of patients with neuropathies. J Neurol (2012) 0.92
Increased pain and neurogenic inflammation in mice deficient of neutral endopeptidase. Neurobiol Dis (2008) 0.91
Magnetic resonance neurography for the diagnosis of extrapelvic sciatic endometriosis. Fertil Steril (2010) 0.91
Nociceptin and its receptor in rat dorsal root ganglion neurons in neuropathic and inflammatory pain models: implications on pain processing. J Peripher Nerv Syst (2006) 0.91
Painful or painless lower limb dysesthesias are highly predictive of peripheral neuropathy: comparison of different diagnostic modalities. Eur J Pain (2008) 0.91
Altered pain behavior and regeneration after nerve injury in TNF receptor deficient mice. J Peripher Nerv Syst (2006) 0.91
Additions required. Dtsch Arztebl Int (2013) 0.90
Department-related tasks and organ-targeted therapy in Fabry disease: an interdisciplinary challenge. Am J Med (2010) 0.90
Early cytokine gene expression in mouse CNS after peripheral nerve lesion. Neurosci Lett (2008) 0.90
Assessment of nerve degeneration by gadofluorine M-enhanced magnetic resonance imaging. Ann Neurol (2005) 0.90
Deficiency of the negative immune regulator B7-H1 enhances inflammation and neuropathic pain after chronic constriction injury of mouse sciatic nerve. Exp Neurol (2010) 0.89
Investigation of the functional brain-derived neurotrophic factor gene variant Val66MET in migraine. J Neural Transm (Vienna) (2008) 0.89
Etiology of small-fiber neuropathy. J Peripher Nerv Syst (2009) 0.89
Anticonvulsants for fibromyalgia. Cochrane Database Syst Rev (2013) 0.88
Epidermal innervation in type 1 diabetic patients: a 2.5-year prospective study after simultaneous pancreas/kidney transplantation. Diabetes Care (2008) 0.88